The implication of monitoring tumour markers: a personalised medicine approach

• In: Poster presentation
• At: Seoul (South Korea) (2017)
• Type: Poster
• Poster code: POS-HPS-003
• By: GRECH, Louise (University of Malta, Pharmacy, Attard, Malta)
• Co-author(s): Charyl Fava: Pharmacy, University of Malta, Msida, Malta
  Louise Grech: Pharmacy, University of Malta, Msida, Malta;Pharmacy, Mater Dei Hospital, Msida, Malta
  Rachel Micallef: Oncology, Sir Anthony Mamo Oncology Centre, Msida, Malta
  Stefan Laspina: Haematology and Oncology, Mater Dei Hospital, Msida, Malta
  Christopher Barbara: Pathology, Mater Dei Hospital, Msida, Malta
  Lilian M. Azzopardi: Pharmacy, University of Malta, Msida, Malta
  
• Abstract:

  Background

  The availability of tumour markers in managing oncology patients contributes to developing personalised pharmacotherapy. 

  Purpose

  To develop and implement a pharmaceutical personalised approach based on harmaceutical care plan (PCP) incorporating tumour markers for patients suffering from ovarian, pancreatic or prostate cancer.

  Methods

  Drug

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login